Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$877K Sell
6,824
-297
-4% -$34.8K 0.11% 107
2026
Q1
$857K Buy
7,121
+28
+0.4% +$3.23K 0.12% 98
2025
Q4
$747K Sell
7,093
-818
-10% -$76.8K 0.11% 110
2025
Q3
$664K Sell
7,911
-317
-4% -$26.1K 0.1% 118
2025
Q2
$651K Buy
8,228
+34
+0.4% +$2.7K 0.1% 114
2025
Q1
$735K Sell
8,194
-857
-9% -$80K 0.13% 109
2024
Q4
$900K Buy
+9,051
New +$933K 0.15% 92

Other funds holding MRK

Crews Bank & Trust's MRK Position: Q2 2026 in Review

Crews Bank & Trust reduced its Merck (MRK) stake by 4.2% in Q2 2026, selling an estimated $34.8K and leaving 6,824 shares worth $877K. The position accounts for 0.11% of the portfolio, ranked #107.

Crews Bank & Trust first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $900K in Q4 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Crews Bank & Trust held 6,824 shares of Merck worth $877K as of Q2 2026.
  • Crews Bank & Trust sold 297 Merck shares in Q2 2026, an estimated $34.8K.
  • Merck made up 0.11% of Crews Bank & Trust's portfolio in Q2 2026, its #107 holding.
  • Crews Bank & Trust first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Crews Bank & Trust's Merck position peaked at $900K in Q4 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.